SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-114654
Filing Date
2021-04-13
Accepted
2021-04-13 16:02:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d130717ds3.htm S-3 163083
2 EX-5.1 d130717dex51.htm EX-5.1 12294
3 EX-23.1 d130717dex231.htm EX-23.1 1409
4 GRAPHIC g130717g0413065656430.jpg GRAPHIC 1785
5 GRAPHIC g130717g48i09.jpg GRAPHIC 44814
  Complete submission text file 0001193125-21-114654.txt   242312
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-255201 | Film No.: 21823096
SIC: 2834 Pharmaceutical Preparations